Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction

Rosenberg, 1975, Actions and interactions of antithrombin and heparin, N. Engl. J. Med., 292, 146, 10.1056/NEJM197501162920307 Rosenberg, 1975, Inhibition of human factor IXa by heparin and antithrombin, J. Biol. Chem., 250, 8883, 10.1016/S0021-9258(19)40667-4 Stead, 1976, Inhibition of activated factor XII by antithrombin-heparin cofactor, J. Biol. Chem., 251, 6481, 10.1016/S0021-9258(17)32973-3 Andersson, 1976, Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration, Thrombos. Res., 9, 575, 10.1016/0049-3848(76)90105-5 Barrowcliffe, 1978, Anticoagulant activities of lung and mucous heparins, Thrombos. Res., 12, 27, 10.1016/0049-3848(78)90082-8 Lane, 1978, Anticoagulant activities of four unfractionated and fractionated heparins, Thrombos. Res., 12, 257, 10.1016/0049-3848(78)90297-9 Yin, 1971, Biological properties of the naturally occurring plasma inhibitor to activated factor X, J. Biol. Chem., 246, 3703, 10.1016/S0021-9258(18)62184-2 Kakkar, 1978, A comparative study of low doses of heparin and a heparin analogue in the prevention of post operative deep vein thrombosis, Thrombos. Res., 13, 111, 10.1016/0049-3848(78)90115-9 Carter, 1980, The relationship between the haemorrhagic and antithrombotic effects of standard and low molecular weight (LMW) heparins, Circulation, 62, III Sugisaki, 1977, Rapid molecular size characterization of heparins by high pressure liquid chromatography, 36, 89 Regoeczi, 1970, Fibrinogen catabolism: Kinetics of catabolism following sudden elevation of the pool with exogenous fibrinogen, Clin. Sci., 38, 111, 10.1042/cs0380111 Yin, 1968, Bovine thrombin and activated factor X. Separation and purification, J. Biol. Chem., 243, 112, 10.1016/S0021-9258(18)99331-2 Chen, 1975, One stage assay of heparin, J. Lab. Clin. Med., 85, 843 Fletcher, 1959, The maintenance of a sustained thrombolytic state in man. I. Induction and effect, J. Clin. Invest., 38, 1096, 10.1172/JCI103886 Teien, 1976, Assay of heparin in plasma using a chromogenic substrate for activated factor X, Thrombos. Res., 8, 413, 10.1016/0049-3848(76)90034-7 Clauss, 1957, Gerinnungsphysiologishe schnell methode zue best immung des fibrinogens, Acta. Haematol., 17, 237, 10.1159/000205234 Proctor, 1961, The PTT with kaolin, Amer. J. Clin. Path., 33, 212, 10.1093/ajcp/36.3.212 Winer, 1971, Statistical principles in experimental design, 191 Carter, 1981, Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin, Thrombos. Res., 21, 169, 10.1016/0049-3848(84)90045-8 Wessler, 1974, On the antithrombotic action of heparin, Thrombos. Diathes. Haemorrh. (Stuttg.), 32, 71 Kakkar, 1974, Low dose heparin in the prevention of venous thromboembolism, Thrombos. Diathes. Haemorrh. (Stuttg.), 33, 87 Barrowcliffe, 1979, Brit. J. Haematol., 41, 573, 10.1111/j.1365-2141.1979.tb05894.x Lane, 1979, Molecular weight dependence of the anticoagulant properites of heparin: Intravenous and subcutaneous administration of fractionated heparins to man, Thrombos. Res., 16, 651, 10.1016/0049-3848(79)90209-3 Kakkar, 1981, Low molecular weight heparin and post operative deep vein thrombosis, Thrombos. Haemostas., 46, 116